Publications including this keyword are listed below.
Katarzyna Kopecka-Piech and Bartłomiej Łódzki’s edited volume, The Covid-19 Pandemic as a Challenge for Media and Communication Studies, could be of great utility to science communication scholars and teachers. The studies with contained within it address two overarching research questions. First, how have media and communication reality changed during the first wave of the Covid-19 pandemic in Europe? Second, how were media and communication studied effectively through that period? The volume features 17 individual studies calling on myriad methods and case examples. This diversity of approaches allows the editors to also address an important, implicit third question. In essence: what has it been like to conduct worthwhile, meaningful, and robust research under such unusual and extreme global circumstances? Each chapter is thorough, detailed and of a high technical standard. This is a book that would likely best serve experienced readers more than novices. The entire compendium bears clear witness to the dynamic nature of social research playing out against a context of enormous global instability.
We analyzed 95,970 stories on COVID-19 published in 2020 by newspapers in US, UK, China and Brazil — countries marked by controversial management of the crisis. Through a text mining approach, we identified main topics, subjects, actors and the level of attention. The coverage was politicized in “The New York Times” and “Folha de S. Paulo”; focused on health aspects in “The Guardian”; and emphasized the economic situation in “China Daily”. In this sense, the pandemic has motivated a deeper approach to the multiple dimensions of science and health, pointing to a broader perspective of science communication.
To map the public information about COVID-19 vaccines and vaccine trials in Europe, we have compiled an inventory of online communication materials from official sources (e.g., governments, public agencies, and NGOs) via directed online research. While information for the general public was abundant across Europe, we found a large variation in number, type and target audiences among countries. Little or no information was found for population groups that are typically underrepresented in vaccine clinical trials. Materials about clinical trials and trial participation were also limited. Interestingly, higher number of media materials was not reflected in higher national vaccination rates.